Controlled Correspondence Assistance

Masuu US Agent assists pharmaceutical companies in drafting, reviewing, authorizing, submitting, and obtaining approval from USFDA for Controlled Correspondence (CC) submissions, a process for generic drug manufacturers to request information related to generic drug development before submitting an ANDA.

Masuu has filed a wide array of Controlled Correspondence including.
  • Q1/Q2 sameness with Reference Listed Drug (RLD)
  • Chemistry Questions, RS Designation
  • MDD of Drug Product
  • Alternative BE Approach
  • Bioequivalence Questions
  • Inactive Ingredients, Formulation/Overage
  • Device Evaluation, Guidance Clarification
  • Drug Shortage
  • RLD Assignment/Availability/Status
  • Retention Samples, Labeling Questions
  • Combination Products
  • Dissolution Specification
  • Filing, and more.

Trust us to streamline your regulatory communication process and ensure clarity and compliance every step of the way.

Book a Demo